Media Dean A. Wetherbee 2/24/26 Media Dean A. Wetherbee 2/24/26 New Initiative Aims to Revive Stalled Rare Disease Therapies Read More Dean A. Wetherbee 12/24/25 Dean A. Wetherbee 12/24/25 Alternative Commercialisation Models Offer Lifeline to Future of Gene Therapies It All Begins Here Read More Dean A. Wetherbee 11/19/25 Dean A. Wetherbee 11/19/25 Alternative Development & Commercialization Strategies for Rare Disease Gene Therapies Read More Dean A. Wetherbee 10/3/25 Dean A. Wetherbee 10/3/25 How Orphan Therapeutics Accelerator is Optimizing Rare Disease Search and Eval Read More Dean A. Wetherbee 4/23/25 Dean A. Wetherbee 4/23/25 How Orphan Therapeutics Accelerator is Optimizing Rare Disease Search and Eval (Copy) Read More Dean A. Wetherbee 3/31/25 Dean A. Wetherbee 3/31/25 Saving Shelved Ultra-Rare Therapies Through Unorthodox Funding Read More Dean A. Wetherbee 10/15/24 Dean A. Wetherbee 10/15/24 When a Miracle Cure is Left on the Shelf Read More Dean A. Wetherbee 3/20/24 Dean A. Wetherbee 3/20/24 Non-Profit Biotech Aims to Revive Stalled Ultrarare Therapies Read More
Media Dean A. Wetherbee 2/24/26 Media Dean A. Wetherbee 2/24/26 New Initiative Aims to Revive Stalled Rare Disease Therapies Read More
Dean A. Wetherbee 12/24/25 Dean A. Wetherbee 12/24/25 Alternative Commercialisation Models Offer Lifeline to Future of Gene Therapies It All Begins Here Read More
Dean A. Wetherbee 11/19/25 Dean A. Wetherbee 11/19/25 Alternative Development & Commercialization Strategies for Rare Disease Gene Therapies Read More
Dean A. Wetherbee 10/3/25 Dean A. Wetherbee 10/3/25 How Orphan Therapeutics Accelerator is Optimizing Rare Disease Search and Eval Read More
Dean A. Wetherbee 4/23/25 Dean A. Wetherbee 4/23/25 How Orphan Therapeutics Accelerator is Optimizing Rare Disease Search and Eval (Copy) Read More
Dean A. Wetherbee 3/31/25 Dean A. Wetherbee 3/31/25 Saving Shelved Ultra-Rare Therapies Through Unorthodox Funding Read More
Dean A. Wetherbee 10/15/24 Dean A. Wetherbee 10/15/24 When a Miracle Cure is Left on the Shelf Read More
Dean A. Wetherbee 3/20/24 Dean A. Wetherbee 3/20/24 Non-Profit Biotech Aims to Revive Stalled Ultrarare Therapies Read More
